Explore the detailed record of transactions filed by Ashe Andrew D., Autre. Officer active across 2 companies, notably Verve Therapeutics, Inc.. Cumulatively, 14 filings have been recorded. Split: 2 buys · 0 sell. Total volume traded: €553k. History available since 2 December 2021. The latest transaction was filed on 14 May 2024 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Ashe Andrew D.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Ashe Andrew D. is a declarant linked to DYAX CORP, where he is General Counsel & EVP, and to Verve Therapeutics, Inc., where the role is listed as See Remarks. The declarant has 14 filings in total, and across the 14 sampled filings from 2016-01-15 to 2025-07-28, buy volume is EUR 553375 and sell volume is EUR 0, with Exercise of options as the most frequent transaction nature.